Sort
51,593 grants matching “hepatitis”
PGC-1 and the Control of Hepatic Gluconeogenesis
$413,478Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2009 · DK
Transplantation of Endothelial Cells
$413,437Sanjeev Gupta · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · DK
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease
$413,410Irina A. Kirpich · University Of Louisville · R01 · FY2024 · AA
REGULATION OF HEME METABOLISM IN THE LIVER
$413,394University Of California San Francisco · R01 · FY2000 · DK
Synthesis: HCV Epidemiology and Prevention in Drug Users
$413,389National Development &Res Institutes · R01 · FY2005 · DA
Glucocorticoid Receptor Coregulators and Insulin Sensitivity
$413,372Jen-Chywan Wang · University Of California Berkeley · R01 · FY2021 · DK
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)
$413,360John C He · Baylor College Of Medicine · P01 · FY2019 · DK
Regulation of CD8 T Cell Immunity by CDK Inhibitor p27Kip1
$413,355Marulasiddappa Suresh · University Of Wisconsin-Madison · R01 · FY2010 · AI
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$413,341Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2022 · AG
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
$413,297Jun Wu · University Of Michigan At Ann Arbor · R01 · FY2022 · AA
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
$413,297Jun Wu · University Of Michigan At Ann Arbor · R01 · FY2025 · AA
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
$413,297Jun Wu · University Of Michigan At Ann Arbor · R01 · FY2021 · AA
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
$413,297Jun Wu · University Of Michigan At Ann Arbor · R01 · FY2024 · AA
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
$413,297Jun Wu · University Of Michigan At Ann Arbor · R01 · FY2023 · AA
Models for Optimal Liver Transplant Outcomes
$413,293W. Ray Kim · Mayo Clinic Rochester · R01 · FY2006 · DK
Apolipoprotein AV and intestinal transport
$413,289Patrick Powing Tso · University Of Cincinnati · R01 · FY2018 · DK
Interferon Alpha as a Tool for Gene Discovery in Human Lupus
$413,266Timothy B Niewold · Mayo Clinic Rochester · R01 · FY2015 · AR
Apo E mimetics reduce cholesterol and improve HDL function
$413,257G M Anantharamaiah · University Of Alabama At Birmingham · R01 · FY2009 · HL
Differentiating Human ESC Towards Hepatocytes
$413,228Mark Allen Zern · University Of California At Davis · R01 · FY2010 · DK
Descriptive Studies and Record Linkage
$413,182Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Conserved Fetal Epigenomic Signatures in a Primate Model of Maternal Obesity
$413,167Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R01 · FY2012 · DK
The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation
$413,160Zhong-Bin Deng · University Of Louisville · R01 · FY2022 · DK
Assessment of hyperthermia-based multimodal approach for hepatic colorectal metastases
$413,158Yong J Lee · Cedars-Sinai Medical Center · R01 · FY2024 · CA
REGULATION OF NET HEPATIC GLUCOSE UPTAKE IN VIVO
$413,002Vanderbilt University · R01 · FY2003 · DK
How IL-10R blockade can resolve persistent viral infections
$412,999Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2010 · AI